AI-Powered knee rehab could replace surgery for common injuries

NCT ID NCT07423819

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new digital system that uses wearable sensors, cameras, and AI to guide people through knee rehab exercises at home. It focuses on two common knee problems: ACL tears and patellar pain. 160 adults aged 18-50 will do strength, balance, and stretching exercises for 6 months, with regular check-ins to see if the digital approach improves knee function and pain better than standard remote rehab.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Digital rehabilitation system (wearable sensors, machine vision, AI) plus muscle strength, balance, and stretching exercises
What this could lead to
If successful, this could provide a more effective, technology-guided home rehab program for common knee injuries, potentially reducing the need for surgery or in-person therapy.
What could go wrong
This is an early-stage trial (not yet recruiting) with no prior results. The digital system's accuracy and patient adherence are unproven, and benefits over standard rehab are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTERIOR CRUCIATE LIGAMENT INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anterior Cruciate Ligament Injuries Patella Fracture patellofemoral pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Jishuitan Hospital

    Beijing, China

  • Peking Union Medical College Hospital

    Beijing, China

  • Peking University People's Hospital

    Beijing, China

  • Peking University Third Hospital

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.